Archived – Association Of Herceptin® (trastuzumab) With Oligohydramnios – For The Public

Recall Summary Herceptin (trastuzumab), a cancer medication, has been associated with oligohydramnios, a condition where there is too little amniotic fluid during pregnancy. This recall affects pregnant women or women who may become pregnant who are taking or considering this drug. Healthcare providers and patients should be aware of this potential risk when using Herceptin during pregnancy.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2009-04-24

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/3954d023-366f-46c6-8e4d-bb300af0222e